UNICLONE

USPTO USPTO 2002 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark UNICLONE was filed as Word mark on 05/24/2002 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 10/07/2003. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details

Trademark form Word mark
File reference 78131079
Register number 2771609
Application date May 24, 2002
Publication date July 15, 2003
Entry date October 7, 2003

Trademark owner

Im Lottental 36
44801 Bochum
DE

Trademark representatives

goods and services

5 Pharmaceutical and veterinarian preparations containing therapeutic proteins, therapeutic nucleicacids, gene and/or cells for health and medical care, namely, for the treatment of allergies, arthritis, cancer, diabetes, diseases of the central nervous system, inflammatory diseases, metabolic disorders, viral diseases; pharmaceutical preparations for use in cardiology and oncology; medical and pharmaceutical products, namely human vaccines, anti-infectives, diagnostic proteins, therapeutic proteins, therapeutic nucleicacids, gene and/or cells; medical, biotechnological and gene-technological products and preparations obtainable by protein-expression-banks and nucleicacid-banks together with expression-vectors, proteomics, proteome-analysis, biochips, comprising proteins and nucleicacids, protein-biochips, arrays for use in or at human beings or animals, namely, proteins; diagnostics and detergents for medical and veterinarian use, namely diagnostic preparations and reagents for clinical or medical laboratory use
9 Scientific devices and instruments for the protein-expression in a protein-expression bank, namely, protein-biochips, comprising clones for identification and validation of proteins and encoding nucleicacids together with expression-vectors thereof
42 Services for chemical, pharmaceutical, biotechnological, diagnostical, analytical, gene-technological, medical laboratories or industrial facilities or research- and development facilities, namely consulting and analysis in the field of chemistry, pharmacy, biotechnology, diagnostic, analytical, gene-technology, bio-informatics, target validation and drug development, by means of nucleicacid- or protein-biochips, protein-expression-banks, nucleicacid-banks, polypeptide or nucleicacid-libraries and arrays, automation, application and use of protein-biochips; consulting and analysis in the field of automation, application and use of proteomics, proteome studies, proteome designs, peptide and protein analytic and identification, purification and characterization, 1 D and 2D gele electrophorese, mass spectrometry, robotics for proteomics and protein-expression-banks

ID: 1378131079